AC Immune director Graney reports 12,959 common shares
The options carry a $2.71 exercise price, an exercise date of June 10, 2027, and an expiration date of October 1, 2036.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AC Immune SA director Thomas Graney reported directly held 12,959 common shares as of October 2, 2026, including 8,936 common shares underlying outstanding restricted share units. He also reported options covering 19,565 common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Common Shares F1 | -- | -- | -- |
Footnotes (1)
- F1. Includes 8,936 common shares underlying outstanding restricted share units.
Key Figures
Key Terms
exercise price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of Thomas Graney's ACIU options?
AI-generated analysis. How Rhea-AI works. Not financial advice.